60 DEGREES PHARMACEUTICALS, INC.: cashflow_financing
| Value | {"amount": 3369752, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-06-30 |
| Status | current |
| Entity | 60 DEGREES PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/97dabc71-3b60-434e-9543-169a48f8ef8d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001554855-26-001860Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946563/cashflow-financing/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/97dabc71-3b60-434e-9543-169a48f8ef8d
History
- no predecessors — first report